title: Advanced colorectal cancer: which regimes should we recommend?
authors.forename: C H
authors.initials: CH
authors.lastname: Koehne
authors.forename: R
authors.initials: R
authors.lastname: Midgley
authors.forename: M
authors.initials: M
authors.lastname: Seymour
authors.forename: D J
authors.initials: DJ
authors.lastname: Kerr
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007261:Infusions, Intra-Arterial; D007262:Infusions, Intravenous; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D011379:Prognosis; D012720:Severity of Illness Index; D016019:Survival Analysis; D015996:Survival Rate
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil